Small single-center study describes dinutuximab beta maintenance for high-risk neuroblastoma
A retrospective study of 13 children at one Chinese center reported 3-year maintenance-phase event-free survival of 69.2% and described adverse ...
A retrospective study of 13 children at one Chinese center reported 3-year maintenance-phase event-free survival of 69.2% and described adverse ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.